- Workers Compensation
- Tractor Trailer Accidents
- Auto Accidents
- Motorcycle Accidents
- Birth Injuries
- Products Liability
- Dangerous Drugs
- Premises Liability/ Slip & Fall
- Social Security Disability
- Wills, Estates & Elder Law
- Links
Previous Posts
- Merck Agreement to Resolve U.S. VIOXX® Product Lia...
- Accutane and Inflammatory Bowel Disease (IBD)
- CNN Special Report
- Fegley named First Vice Chair for AAJ
- Erectile Dysfunction Drugs May Produce Many Side E...
- PharmaFab
- FDA Recommends Medical Device User Fee Program
- CONGRATULATIONS!!
- Cardiac Risk - AVANDIA
- Two New Resources
![]()
O'Connor Law
Monday, November 26, 2007
MRI Contrast Agent Gadolinium Blamed for Young Man's Death
Drake's mother, Beverly Rockwell, is seeking compensatory and punitive damages on behalf of her son. The lawsuit specifically claims that Magnevist caused Nephrogenic Systemic Fibrosis (NSF), a skin and joint disease which proved to be fatal to the young man. NSF, also known as Nephrogenic Fibrosing Dermopathy (NFD), is a condition that only develops in patients with kidney disease. Patients with NSF/NFD have swelling and tightening of the skin, usually only involving the extremities but sometimes affecting the torso. The thickening and swelling of the skin inhibits flexion and extension of the arms and legs, and severely affected patients may even be unable to walk.
In 2006, the Food and Drug Administration (FDA) reported that there were 200 reports worldwide of NSF/NSD cases that had developed following patient exposure to gadolinium-based contrast agents; many of these cases were fatal. In mid-May 2007, the FDA advised the makers of gadolinium-based contrast agents to place a "Boxed Warning" about the risks of developing NSF/NFD after being injected with Magnevist. A boxed warning is also referred to as a black label warning and means that medical studies indicate the drug carries a significant risk of serious and even life-threatening side effects. A black label warning is the strongest warning the FDA issues prescription drugs.
For more information, contact the Law Offices of Michael J. O'Connor & Associates at 800-518-4529, or visit our website to fill out one of the contact forms (www.oconnorlaw.com). The initial consultation is free, and the firm works on a contngency fee basis, so you pay nothing unless we recover money for you.
posted by Michael J. O'Connor & Associates at 8:10 AM
Disclaimer
Michael J. O'Connor & Associates - Pennsylvania Attorneys providing a full range of legal services including Wills, Estates and Elder Law, Personal Injury, Auto Accidents, Motorcycle Accidents, Defective Products, Premise Liability, Wage and Hour Laws, Social Security and Workers Compensation Claims.
For your convenience, we have offices located throughout Pennsylvania including Allentown, Bala Cynwyd, Bloomsburg, Frackville, Hazelton, Lancaster, Lock Haven, Philadelphia, Reading, Scranton, State College, Stroudsburg, Sunbury, Wilkes-Barre and Williamsport.
Website design, development and Search Engine Optimization (SEO) by Page 1 Solutions, LLC.






<< Home